Pre-announcement of a financial report according to articles 114 - 117 WpHG
Biofrontera reports rise in Q4 revenue, turns profitable
Financial Guidance for FY 2026
PTA-Adhoc: Biofrontera AG: Forecast Increase
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025
Biofrontera AG completes sale of U.S. Ameluz® and RhodoLED® assets to Biofrontera Inc.